Intrinsiqs

Is Novavax, Inc. overvalued?

Novavax, Inc. (NVAX) — key valuation metrics and fundamentals.

No verdict
Price
$8.05
Fair value
Current P/E
Normal P/E
Market cap
$1.32B
Dividend yield
0.0%
Return on equity
159.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NVAX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.